Amalgamated Bank Curis Inc Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $9,707 - $33,222	-13,672 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$2.31 - $5.13 $2,541 - $5,643	-1,100 Reduced 7.45%	13,672 $33,000
Q4 2021 Feb 15, 2022	SELL	$4.45 - $8.09 $1,246 - $2,265	-280 Reduced 1.86%	14,772 $70,000
Q3 2021 Oct 29, 2021	SELL	$6.94 - $8.85 $5,316 - $6,779	-766 Reduced 4.84%	15,052 $118,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $117,844 - $257,358	15,818 New	15,818 $128,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.